Why the study?
Is the angiotensin converting enzyme gene insertion/deletion polymorphism associated with progressive renal disease?
Is the angiotensin converting enzyme gene insertion/deletion polymorphism associated with progressive renal disease?
This review highlights the potential role of the ACE gene insertion/deletion polymorphism in progressive renal disease and suggests future strategies for identifying genetic markers in nephrology.
No takes yet. Share an insight, caveat, or question.
Does not support ACE I/D genotyping in renal disease management; leaves open its role pending larger, standardized studies.
Jardine et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: